CANbridge signs WuXi Biologics CRDMO services framework agreement with RMB 39.8 million 2026 cap

  • CANbridge Pharmaceuticals entered a service procurement framework agreement with WuXi Biologics covering CRDMO services through Dec. 31, 2028.
  • Annual caps set at RMB 39.8 million for 2026, RMB 70.7 million for 2027, RMB 70.7 million for 2028.
  • WuXi Biologics holds 16.21% of CANbridge, triggering independent shareholder approval for the framework agreement.
  • Separate supporting-services procurement framework signed with Baheal Medical through Dec. 31, 2028, with caps of RMB 1.5 million, RMB 2 million, RMB 2 million.
  • Baheal Medical holds about 16.26% of CANbridge; the arrangement requires reporting and annual review, not independent shareholder approval.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Canbridge Pharmaceuticals Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260616-12205391), on June 16, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.